a3838j

6-K 1 a3838j.htm Q3 2024 TRADING STATEMENT a3838j

表格6-K

证券及交易委员会

华盛顿特区20549

外国发行人报告

根据证券交易法规则13a-16或15d-16

1934年证券交易法第13a-16或15d-16条款

日期为2024年10月24日

委员会文件编号：001-04546

联合利华(英国) PLC

(将注册人的姓名翻译成英文)

英国伦敦黑色星期五联合利华大厦

(总部地址)

用勾号表示，注册者是否提交或将提交年度报告

根据20-F表格或40-F表格申报。

表格 20-F..X.. 表格 40-F

在纸张上标注上勾号表示注册人正在提交6-k表格

根据S-t规则101(b)(1)的规定：_____

在纸张上标注上勾号表示注册人正在提交6-k表格

根据S-t规则101(b)(7)的规定：_____

勾选示意是否通过提供信息的方式进行登记

在这个表格中包含的信息也因此向

根据1934年证券交易所法案第12g3-2(b)条规定，委员会

是不可以 .X..

如果选中“是”，请在下面标明分配给注册人的文件号码。

根据规则12g3-2(b)：82- _______ 的相关事项

本文件附件99已在此引用。

签名

根据1934年证券交易法的要求，申报人已经授权其代表在其名义下签署本报告。

联合利华(英国) PLC

/S/ 中单 VARSELLONA

BY 中单 VARSELLONA

首席法务官兼集团秘书

日期: 2024年10月24日

展览指数

------------------------

展览编号	展品描述
99	2024年10月24日致伦敦证券交易所的通知
	2024年第三季度交易声明

展品99

联合利华贸易声明-2024年第三季度

成交量驱动增长，在所有业务群体中保持积极态势

	2024年第三季度			2024年前九个月
(未经审计)	美国石膏公司	营业额	比2023年	USG	营业额	比2023年
联合利华(英国)	4.5%	152亿欧元	-%	4.3%	464亿欧元	1.3%
美容与健康	6.7%	32亿欧元	5.5%	7.0%	98亿欧元	5.1%
个人护理	4.4%	3.4亿欧元	(5.7)%	5.2%	10.4亿欧元	(1.6)%
家居护理	1.9%	3.0亿欧元	(2.9)%	2.8%	9.3亿欧元	-%
营养	1.5%	3.2亿欧元	(1.5)%	2.6%	9.9亿欧元	0.3%
冰淇淋奶油	9.8%	€2.4亿	8.1%	3.6%	70亿欧元	3.9%

第三季度亮点

● 持续销售增长（USG）率为4.5％，成交量增长率提高至3.6％

● 强势品牌 (75%以上的营业额)以领先增长5.4%的USG和销量增长4.3%

● 营业额为152亿欧元受货币(2.8)%和净处置(1.5)%的影响

● 2024全年展望不变以3-5%美国增长率，以及至少18%的基本营业利润率

● 最终阶段正在进行中 2024年高达15亿欧元的股票回购计划

● 生产力项目和冰淇淋分离计划进展顺利

首席执行官声明

我们已经连续第四个季度实现了正增长的成交量，我们的每一个业务组都推动了年度成交量的增长

基础销售增长4.5%，由我们的核心品牌主导，其中Dove，Liquid I.V.，Comfort和Magnum表现尤为出色。价格增长继续温和，符合我们的预期。

我们仍处于转变绩效的早期阶段，我们正在以加快的速度执行增长行动计划 - 专注于做更少的事情，做得更好，并产生更大的影响。我们开始看到在市场上推广更少、更大的创新，并得到增加品牌投资的积极影响。我们正在采取果断行动，针对运营或市场挑战，确保我们为持续和改善的绩效做好了充分准备。作为集团整体转型的一部分，我们正在实施全面的生产力方案和冰淇淋业务的分拆，这两者都在按计划进行。

我们正在按计划实现2024年的展望，并相信我们正在采取的步骤将有助于将联合利华(英国)逐步转变为一个表现持续更佳的业务。

Hein Schumacher

展望

我们2024年全年展望不变。

我们继续预计2024年的基础销售增长（USG）将在我们多年的区间内，即3%至5%之间，其中大部分增长将由成交量推动。

预计全年基础营业利润率至少为18%，在我们的品牌背后进行增加投资。我们预计下半年的利润率逐年增长将小于上半年。

第三季度审查：联合利华(英国)集团

增长

(未经审计)	营业额	USG	UVG	UPG	收购	处置	货币	营业额变动
第三季度	152亿欧元	4.5%	3.6%	0.9%	0.3%	(1.8)%	(2.8)%	-%
九个月	464亿欧元	4.3%	2.9%	1.3%	0.4%	(1.4)%	(1.9)%	1.3%

在市场增长放缓的背景下，第三季度基础销售增长率为4.5%。基础成交量增长率（UVG）在Q3达到了3.6%，这是连续第四个实现正增长和改善的季度。所有业务板块均实现了正成交量增长。正如预期的那样，基础价格增长在Q3继续保持在0.9%的水平。

Power Brands表现强劲，基础销售增长率达5.4%，其中成交量增长率为4.3%。我们的其他品牌也在第三季度实现了1.3%的成交量增长，较上半年的(1.6)%有所提升。

美容与健康业务的潜在销售额增长了6.7%，成交量增长了5.7%。健康与健康以及高级美容融合的业务连续第十五个季度实现了双位数、成交量引领的增长。在美容市场在美国和中国持续放缓的背景下，健康与健康业务强劲增长的表现超过了高级美容的较弱增长。个人护理业务增长了4.4%，其中3.1%来自成交量增长，表现强劲。多芬家庭护理的潜在销售额增长了1.9%，3.3%的成交量增长超过了与商品成本通货紧缩相关联的持续负面价格增长。营养品的潜在销售额增长了1.5%，在价格和市场放缓的背景下，已降低的0.4%的成交量增长。冰淇淋销售额增长了9.8%，成交量增长了6.7%，价格增长了2.9%。这一良好的表现反映了持续专注于运营改进以及强劲创新，加剧了弱对照组带来的影响。

发达市场（集团营业额的43%）的潜在销售增长了6.9%，其中6.8%来自成交量，0.1%来自价格。成交量增长基础广泛，并反映了北美美容与健康领域的强劲增长，欧洲家居保洁业务的强劲增长以及冰淇淋销量的显著提升。如预期的那样，价格增长进一步减缓。

新兴市场（集团营业额的57%）的潜在销售增长2.9%，其中1.4%来自成交量，1.5%来自价格。印度的销售增长了2.3%，成交量增长了3.4%。印度的基础价格增长率为（1.0）%，去年同期的一次性间接税收优惠的涨势已过，没有这一项，第三季度的增长率将是持平的。拉丁美洲增长了3.8%。这种较慢的增长率反映出巴西的洗衣粉市场下滑以及墨西哥在在连续八个季度双位数增长之后低个位数的增长。非洲和土耳其持续实现双位数增长。

中国在各类别市场疲软的情况下，单个数字下降，因此我们正在转变我们的市场策略。东南亚下降了个位数，这主要是由印度尼西亚的下滑（18%）部分抵消，而菲律宾和泰国的成交量拉动了增长。

我们正在印度尼西亚做果断干预，解决我们长期存在的问题，包括在各个渠道消除价格不稳定，将零售库存水平重置为我们认为的最佳水平。我们预计从2025年下半年开始，在印度尼西亚和中国看到这些变化带来的好处。

152亿欧元的营业额与去年持平，由于基础销售增长被(2.8)%的货币影响和(1.5)%的处置净额和收购所抵消。

冰淇淋分离和生产效率项目进展

在三月，我们宣布了将冰淇淋业务分拆并启动了一项重要的生产力计划，以加强公司并显著提高我们的效率和效果。

分拆活动计划在2025年底前完成。我们正在推进法律实体的设立，独立运营模式以及财务拆分。

7月份，我们在内部就计划中的生产力项目变化进行了沟通，以简化我们的业务并进一步发展我们基于类别的运营模式。我们已经开始在那些与各自工会协商完成的国家/地区进行实施。

资本配置

2024年8月2日，我们已完成了对秦远集团（也称为“Truliva”）的股权出售，该集团向中国家庭提供一系列的水净化解决方案，交易对象是永朝创投有限公司。

2024年10月10日，我们将俄罗斯子公司销售给阿涅斯特集团。此次交易包括联合利华(英国)在俄罗斯的所有业务以及其四家工厂，以及我们在白俄罗斯的业务。

2024年2月，我们宣布了一个股票回购计划，将在2024年内进行15亿欧元的回购。第一批7千万欧元于8月完成。第二批最多8千万欧元于9月启动，并将于2024年12月完成。

After the quarterly interim dividend for the second quarter was raised by 3.0% to €0.4396, the quarterly interim dividend for the third quarter is maintained at this level.

Conference Call

Following the release of this trading statement on 24 October 2024 at 7:00 AM (UK time), there will be a live webcast at 8:00 AM available on the website www.unilever.com/investor-relations/results-and-presentations/latest-results.

A replay of the webcast and the slides of the presentation will be made available after the live meeting.

Upcoming Events

Date	Events
22 November 2024	Unilever Investor Event 2024
13 February 2025	Q4 and FY 2024 results

Third Quarter Review: Business Groups

	Third Quarter 2024				Nine Months 2024
(unaudited)	Turnover	USG	UVG	UPG	Turnover	USG	UVG	UPG
Unilever	€15.2bn	4.5%	3.6%	0.9%	€46.4bn	4.3%	2.9%	1.3%
Beauty & Wellbeing	€3.2bn	6.7%	5.7%	0.9%	€9.8bn	7.0%	5.6%	1.3%
Personal Care	€3.4bn	4.4%	3.1%	1.3%	€10.4bn	5.2%	3.0%	2.2%
Home Care	€3.0bn	1.9%	3.3%	(1.4)%	€9.3bn	2.8%	4.2%	(1.3)%
Nutrition	€3.2bn	1.5%	0.4%	1.1%	€9.9bn	2.6%	0.1%	2.5%
Ice Cream	€2.4bn	9.8%	6.7%	2.9%	€7.0bn	3.6%	1.5%	2.1%

Beauty & Wellbeing (21% of Q3 turnover)

In Beauty & Wellbeing, we focus on three key priorities that will drive the unmissable superiority of our brands: elevating our core Hair Care and Skin Care brands to increase premiumisation; fuelling the growth of Prestige Beauty and Health & Wellbeing with selective international expansion; and continuing to strengthen our beauty and wellbeing capabilities.

(unaudited)	Turnover	USG	UVG	UPG	Acquisitions	Disposals	Currency	Turnover change
Third Quarter	€3.2bn	6.7%	5.7%	0.9%	1.0%	-%	(2.1)%	5.5%
Nine Months	€9.8bn	7.0%	5.6%	1.3%	0.9%	(1.1)%	(1.6)%	5.1%

Beauty & Wellbeing delivered a strong performance, with underlying sales up 6.7%, driven by volume up 5.7% and price up 0.9%.

Hair Care delivered low-single digit growth with low-single digit volume growth. Dove continued to deliver volume-led growth following the first half launch of Scalp + Hair Therapy, while TRESemmé grew mid-single digit with continued success of its treatments and styling range. Our largest hair care brand, Sunsilk, grew low-single digit and Clear achieved high-single digit growth outside China, but was flat overall.

Core Skin Care grew mid-single digit led by double-digit volume growth in the United States. Dove achieved strong double-digit growth, which included the launch of High Potency Body Serums and 3-in-1 face care treatments in Brazil. Pond's grew double-digit supported by our Bright Miracle and Age Miracle face care ranges, featuring advanced technologies for clearer, more youthful skin. Vaseline continued to perform well, supported by the continued rollout of premium innovations like Radiant X and Gluta Hya, as well as the launch of Pro VitaB3 Serum-Burst Lotion in the United States.

Health & Wellbeing and Prestige Beauty combined delivered double-digit growth for the fifteenth consecutive quarter. This was led by very strong growth in Health & Wellbeing, which offset lower growth in Prestige Beauty reflecting the continued slowdown in the United States and China beauty markets. Liquid I.V. delivered another quarter of strong double-digit growth, driven by a successful summer season and continued international expansion. Nutrafol and Olly also saw strong double-digit growth, with Olly's female health supplements performing well in China. Hourglass led Prestige growth with strong double-digit growth, driven by hero products such as Vanish Airbrush Concealer and Veil Hydrating Skin Tint, while Paula's Choice was impacted by the market slowdown.

Personal Care (22% of Q3 turnover)

In Personal Care, we focus on winning with science-led brands that deliver unmissable superiority to our consumers across Deodorants, Skin Cleansing, and Oral Care. Our priorities include developing superior technology and multi-year innovation platforms, leveraging partnerships with our customers, and expanding into premium areas and digital channels.

(unaudited)	Turnover	USG	UVG	UPG	Acquisitions	Disposals	Currency	Turnover change
Third Quarter	€3.4bn	4.4%	3.1%	1.3%	-%	(6.3)%	(3.6)%	(5.7)%
Nine Months	€10.4bn	5.2%	3.0%	2.2%	-%	(4.4)%	(2.1)%	(1.6)%

Personal Care delivered volume-led growth with underlying sales up 4.4%, driven by volume up 3.1% and price up 1.3%.

Deodorants grew high-single digit, which was volume-led. Latin America led growth with double-digit volume, while Europe and North America saw mid-single digit increases. Dove continued to grow double-digit with strength across both core women and Dove Men+Care ranges, including our expansion into the whole body deodorants market in the first half. Axe and Rexona continued to grow, driven by the ongoing success of our fine fragrance and clinical ranges.

Skin Cleansing grew low-single digit fully driven by volume. In Europe, we achieved high-single digit growth driven by volume increases, while in the United States, we saw mid-single digit growth. Dove delivered high-single digit growth, supported by the first-half relaunch of Dove's body wash in Europe and the launch of Dove's premium body wash range infused with skincare serums in the United States. Growth was tempered by deflation in India, category declines in China, and operational challenges in Indonesia.

Oral Care grew low-single digit with mid-single digit growth in Europe partially offset by a decline in Indonesia.

Home Care (20% of Q3 turnover)

In Home Care, we focus on delivering for consumers who want superior products that are sustainable and great value. We drive growth through unmissable superiority in our biggest brands, in our key markets and across channels. We have a resilient business that spans price points and grows the market by premiumising and trading consumers up to additional benefits.

(unaudited)	Turnover	USG	UVG	UPG	Acquisitions	Disposals	Currency	Turnover change
Third Quarter	€3.0bn	1.9%	3.3%	(1.4)%	-%	(1.2)%	(3.6)%	(2.9)%
Nine Months	€9.3bn	2.8%	4.2%	(1.3)%	-%	(0.4)%	(2.3)%	-%

Home Care underlying sales grew 1.9%, with volume growth of 3.3%, partially offset by a (1.4)% price decline.

Fabric Cleaning declined low-single digit as slightly positive volume was more than offset by low-single digit negative price. Europe led with high-single digit growth, driven by double-digit volume. Persil Wonder Wash, featuring our patented Pro-S technology designed for short cycle washes, continued to perform well and was launched in Turkey in Q3. In India, we grew high-single digit driven by strong volumes and double-digit growth in liquids led by our Surf Excel Matic and Rin ranges. Brazil saw declines in both price and volume due to a softening market and commodity deflation, particularly affecting our powders portfolio.

Home & Hygiene grew mid-single digit led by volume. Domestos grew double-digit led by momentum in our Power Foam range which expanded to new geographies including Poland and Turkey. Cif also maintained double-digit, volume-led growth.

Fabric Enhancers grew double-digit with strong volumes slightly offset by negative price. Comfort continued to deliver double-digit volume growth following the successful first-half launch of our new, Botanicals and Elixir ranges, with our patented CrystalFresh technology.

Nutrition (21% of Q3 turnover)

In Nutrition, our strategy is to deliver consistent, competitive growth by offering unmissably superior products through our biggest brands. We do this by reaching more consumers and focusing on top dishes and high consumption seasons to satisfy consumer's preferences on taste, health and sustainability; while delivering productivity and resilience in our supply chain.

(unaudited)	Turnover	USG	UVG	UPG	Acquisitions	Disposals	Currency	Turnover change
Third Quarter	€3.2bn	1.5%	0.4%	1.1%	-%	(0.5)%	(2.5)%	(1.5)%
Nine Months	€9.9bn	2.6%	0.1%	2.5%	-%	(0.4)%	(1.9)%	0.3%

Nutrition underlying sales grew 1.5%, driven by positive price and volume.

Scratch Cooking Aids grew low-single digit, led by mid-single digit growth in Knorr. In Latin America, we achieved double-digit growth, driven by strong performance from our next generation bouillon & seasoning ranges with enhanced flavours and micronutrients. In the United States, we saw mid-single digit growth, entirely volume-driven, benefiting from social-first campaigns promoting home cooking with bouillon.

Dressings was flat with low-single digit volume offset by negative price. Hellmann's delivered low-single digit volume growth which was offset by negative price as promotional intensity increased. Flavoured mayo continued to perform well with rapid geographic expansion, including recent launches in Argentina and the Philippines.

Unilever Food Solutions grew low-single digit with positive volumes despite a slowdown in China. We continued to expand our digital selling programme and benefited from the launch of Hellmann's Professional Mayo in Europe and Brazil, specifically designed for professional kitchens.

Ice Cream (16% of Q3 turnover)

In Ice Cream, our immediate strategic priority is to expand operating profit and global market share. We will do this by building the unmissable superiority of our brands, accelerating market development in emerging markets, continuing to lead the industry on innovation and premiumisation, and by stepping up our performance and productivity. In March, we announced the planned separation of Ice Cream which we expect to be completed by the end of 2025. The separation will create a world-leading business, operating in a highly attractive category with five of the top 10 selling global ice cream brands.

(unaudited)	Turnover	USG	UVG	UPG	Acquisitions	Disposals	Currency	Turnover change
Third Quarter	€2.4bn	9.8%	6.7%	2.9%	0.7%	-%	(2.3)%	8.1%
Nine Months	€7.0bn	3.6%	1.5%	2.1%	1.5%	-%	(1.2)%	3.9%

Ice Cream underlying sales grew 9.8%, with 6.7% from volume and 2.9% from price. This improved performance was driven by operational strengthening, including distribution gains and optimised promotional activities, alongside strong innovations. These improvements were amplified by a weak Q3 2023 comparator.

In-home grew double-digit led by double-digit volume growth in Europe. Magnum's first bite-sized innovation, Bon Bons, along with Ben & Jerry's Peaces and Yasso's Poppables, performed well. These premium micro-format innovations cater to the demand for smaller, frequent indulgences, driving growth in the Ice Cream category year-round.

Out-of-home grew high-single digit with positive volume and price growth. Magnum achieved double-digit growth, with continued strong performance of its premium 'Pleasure Express' range, featuring Euphoria, Wonder, and Chill. Ben & Jerry's and Cornetto saw high-single digit growth, supported by Cornetto's first global relaunch with enhanced formulation and new packaging.

Third Quarter Review: Geographical Areas

	Third Quarter 2024				Nine Months 2024
(unaudited)	Turnover	USG	UVG	UPG	Turnover	USG	UVG	UPG
Unilever	€15.2bn	4.5%	3.6%	0.9%	€46.4bn	4.3%	2.9%	1.3%
Asia Pacific Africa	€6.5bn	2.5%	1.0%	1.5%	€19.9bn	3.2%	2.0%	1.2%
The Americas	€5.5bn	5.9%	4.6%	1.3%	€16.9bn	5.6%	4.1%	1.4%
Europe	€3.2bn	6.5%	7.7%	(1.0)%	€9.6bn	4.5%	2.9%	1.5%

	Third Quarter 2024				Nine Months 2024
(unaudited)	Turnover	USG	UVG	UPG	Turnover	USG	UVG	UPG
Emerging markets	€8.7bn	2.9%	1.4%	1.5%	€27.0bn	4.4%	3.0%	1.3%
Developed markets	€6.5bn	6.9%	6.8%	0.1%	€19.4bn	4.1%	2.8%	1.3%
North America	€3.3bn	7.4%	6.2%	1.1%	€10.0bn	4.7%	3.4%	1.3%
Latin America	€2.2bn	3.8%	2.0%	1.7%	€6.9bn	7.0%	5.3%	1.6%

Asia Pacific Africa (43% of Q3 turnover)

Underlying sales growth was 2.5% with 1.0% from volume and 1.5% from price.

India grew 2.3% driven by volume at 3.4%. Price at (1.0)% lapped an indirect tax one-off in the 2023 base; excluding this, Q3 UPG would have been flat. Growth was led by strong volume in both Beauty & Wellbeing and Home Care. Africa and Turkey continued to grow double-digit with positive price and volume.

China declined low-single digit amidst continued weak consumer sentiment. In addition, we are resetting our go-to-market approach with higher category focus, updated channel strategies and sharper geographic choices. We appointed new leadership in China, and we will continue to build on our strong positions in core categories.

Underlying sales declined (18)% in Indonesia, primarily due to our long-standing operational issues.

We are taking significant actions in Indonesia, which include removing price instability across channels and resetting stock levels in retail to what we consider optimum levels.

We expect to see the benefits of the changes in Indonesia and China from the second half of 2025.

The Americas (36% of Q3 turnover)

Underlying sales grew 7.4% in North America with 6.2% from volume and 1.1% from price. Beauty & Wellbeing delivered double-digit, volume-led growth, driven by a strong performance in Health & Wellbeing and continued good momentum in Vaseline. Personal Care saw a balanced mid-single digit growth, supported by Dove. Nutrition grew low-single digit with positive volume and price, but reflecting a slowdown in category growth. Ice Cream contributed high-single digit volume growth and positive price supported by strong Popsicle SpongeBob and Minions innovations.

Underlying sales in Latin America decelerated to 3.8% with 2.0% volume and 1.7% price. Beauty & Wellbeing and Personal Care grew high-single digit with positive price and volume, led by double-digit volume growth in Deodorants and Skin Care. Home Care declined low-single digit, adversely affected by a slowdown in Brazil powders' market. Nutrition grew mid-single digit with a strong performance from Knorr. Ice Cream declined low-single digit driven by adverse weather conditions in the region. Brazil grew low-single digit with strong growth from Beauty & Wellbeing and Personal Care. Mexico experienced low-single digit growth as pricing and volumes began to normalise after double-digit growth over the previous eight quarters. Despite ongoing economic adjustments in Argentina and continued hyperinflationary pricing, we delivered positive volume growth.

Europe (21% of Q3 turnover)

Underlying sales grew 6.5% with volume growth of 7.7% partially offset by negative price of (1.0)%. Our stepped-up performance in Europe was underpinned by a strong innovation programme and increased levels of brand investment. Ice Cream and Home Care delivered double-digit, volume-led growth, while Personal Care grew mid-single digit, led by another quarter of strong volume growth in Deodorants. Nutrition was slightly positive. Growth was broad-based in Europe, with all major markets delivering positive volume growth in the quarter.

Dividends

The Board has declared a quarterly interim dividend for Q3 2024 of £0.3663 per Unilever PLC ordinary share or €0.4396 per Unilever PLC ordinary share at the applicable exchange rate issued by WM/Reuters on 22 October 2024.

The following amounts will be paid in respect of this quarterly interim dividend on the relevant payment date:

Per Unilever PLC ordinary share (traded on the London Stock Exchange):	£0.3663
Per Unilever PLC ordinary share (traded on Euronext in Amsterdam):	€0.4396
Per Unilever PLC American Depositary Receipt:	US$0.4755

The euro and US dollar amounts above have been determined using the applicable exchange rates issued by WM/Reuters on 22 October 2024.

US dollar cheques for the quarterly interim dividend will be mailed on 06 December 2024 to holders of record at the close of business on 08 November 2024.

The quarterly dividend calendar for the remainder of 2024 will be as follows:

	Announcement Date	Ex-dividend Date for Ordinary Shares	Ex-dividend Date for ADRs	Record Date	Payment Date
Q3 2024 Dividend	24 October 2024	07 November 2024	08 November 2024	08 November 2024	06 December 2024

Segment Information - Business Groups

(unaudited)
Third Quarter	Beauty & Wellbeing	Personal Care	Home Care	Nutrition	Ice Cream	Total
Turnover (€ million)
2023	3,106	3,597	3,084	3,250	2,205	15,242
2024	3,276	3,393	2,993	3,201	2,383	15,246
Change (%)	5.5	(5.7)	(2.9)	(1.5)	8.1	-
Impact of:
Acquisitions (%)	1.0	-	-	-	0.7	0.3
Disposals (%)	-	(6.3)	(1.2)	(0.5)	-	(1.8)
Currency-related items (%), of which:	(2.1)	(3.6)	(3.6)	(2.5)	(2.3)	(2.8)
Exchange rates changes (%)	(3.7)	(5.3)	(6.6)	(4.4)	(4.4)	(4.9)
Extreme price growth in hyperinflationary markets*	1.7	1.8	3.2	2.0	2.2	2.2
Underlying sales growth (%)	6.7	4.4	1.9	1.5	9.8	4.5
Price* (%)	0.9	1.3	(1.4)	1.1	2.9	0.9
Volume (%)	5.7	3.1	3.3	0.4	6.7	3.6

Nine Months	Beauty & Wellbeing	Personal Care	Home Care	Nutrition	Ice Cream	Total
Turnover (€ million)
2023	9,343	10,515	9,325	9,861	6,733	45,777
2024	9,817	10,349	9,326	9,890	6,996	46,378
Change (%)	5.1	(1.6)	-	0.3	3.9	1.3
Impact of:
Acquisitions (%)	0.9	-	-	-	1.5	0.4
Disposals (%)	(1.1)	(4.4)	(0.4)	(0.4)	-	(1.4)
Currency-related items (%), of which:	(1.6)	(2.1)	(2.3)	(1.9)	(1.2)	(1.9)
Exchange rates changes (%)	(3.2)	(3.9)	(5.5)	(3.6)	(3.2)	(3.9)
Extreme price growth in hyperinflationary markets*	1.6	1.9	3.3	1.8	2.1	2.1
Underlying sales growth (%)	7.0	5.2	2.8	2.6	3.6	4.3
Price* (%)	1.3	2.2	(1.3)	2.5	2.1	1.3
Volume (%)	5.6	3.0	4.2	0.1	1.5	2.9

* Underlying price growth in excess of 26% per year in hyperinflationary economies has been excluded when calculating the price growth in the tables above, and an equal and opposite amount is shown as extreme price growth in hyperinflationary markets.

Turnover growth is made up of distinct individual growth components namely underlying sales, currency impact, acquisitions and disposals. Turnover growth is arrived at by multiplying these individual components on a compounded basis as there is a currency impact on each of the other components. Accordingly, turnover growth is more than just the sum of the individual components.

Segment Information - Geographical Areas

(unaudited)
Third Quarter	Asia Pacific Africa	The Americas	Europe	Total
Turnover (€ million)
2023	6,600	5,525	3,117	15,242
2024	6,493	5,478	3,275	15,246
Change (%)	(1.6)	(0.9)	5.1	-
Impact of:
Acquisitions (%)	-	0.9	-	0.3
Disposals (%)	(0.9)	(3.1)	(1.8)	(1.8)
Currency-related items (%), of which:	(3.2)	(4.3)	0.4	(2.8)
Exchange rates changes (%)	(4.7)	(8.1)	0.4	(4.9)
Extreme price growth in hyperinflationary markets*	1.6	4.2	-	2.2
Underlying sales growth (%)	2.5	5.9	6.5	4.5
Price* (%)	1.5	1.3	(1.0)	0.9
Volume (%)	1.0	4.6	7.7	3.6

Nine Months	Asia Pacific Africa	The Americas	Europe	Total
Turnover (€ million)
2023	20,141	16,467	9,169	45,777
2024	19,869	16,950	9,559	46,378
Change (%)	(1.3)	2.9	4.3	1.3
Impact of:
Acquisitions (%)	-	1.1	-	0.4
Disposals (%)	(0.5)	(2.9)	(0.8)	(1.4)
Currency-related items (%), of which:	(3.9)	(0.7)	0.6	(1.9)
Exchange rates changes (%)	(5.4)	(4.6)	0.6	(3.9)
Extreme price growth in hyperinflationary markets*	1.5	4.1	-	2.1
Underlying sales growth (%)	3.2	5.6	4.5	4.3
Price* (%)	1.2	1.4	1.5	1.3
Volume (%)	2.0	4.1	2.9	2.9

Non - GAAP measures

In our financial reporting we use certain measures that are not defined by generally accepted accounting principles (GAAP) such as IFRS. We believe this information, along with comparable GAAP measurements, is useful to investors because it provides a basis for measuring our operating performance, and our ability to retire debt and invest in new business opportunities. Our management uses these financial measures, along with the most directly comparable GAAP financial measures, in evaluating our operating performance and value creation. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with GAAP. Wherever appropriate and practical, we provide reconciliations to relevant GAAP measures. The non-GAAP measures used in this announcement are underlying sales growth, underlying volume growth and underlying price growth (see below).

Underlying sales growth (USG)

Underlying sales growth (USG) refers to the increase in turnover for the period, excluding any change in turnover resulting from acquisitions, disposals, changes in currency and price growth in excess of 26% in hyperinflationary economies. Inflation of 26% per year compounded over three years is one of the key indicators within IAS 29 to assess whether an economy is deemed to be hyperinflationary. We believe this measure provides valuable additional information on the underlying sales performance of the business and is a key measure used internally. The impact of acquisitions and disposals is excluded from USG for a period of 12 calendar months from the applicable closing date. Turnover from acquired brands that are launched in countries where they were not previously sold is included in USG as such turnover is more attributable to our existing sales and distribution network than the acquisition itself. The reconciliation of changes in the GAAP measure turnover to USG is provided on page 9 and 10.

Underlying price growth (UPG)

Underlying price growth (UPG) is part of USG and means, for the applicable period, the increase in turnover attributable to changes in prices during the period. UPG therefore excludes the impact to USG due to (i) the volume of products sold; and (ii) the composition of products sold during the period. In determining changes in price we exclude the impact of price growth in excess of 26% per year in hyperinflationary economies as explained in USG above. The measures and the related turnover GAAP measure are set out on page 9 and 10.

Underlying volume growth (UVG)

Underlying volume growth (UVG) is part of USG and means, for the applicable period, the increase in turnover in such period calculated as the sum of (i) the increase in turnover attributable to the volume of products sold; and (ii) the increase in turnover attributable to the composition of products sold during such period. UVG therefore excludes any impact on USG due to changes in prices. The measures and the related turnover GAAP measure are set out on page 9 and 10.

Cautionary Statement

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995, concerning the financial condition, results of operations and businesses of the Unilever Group (the 'Group'). All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Words and terminology such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', 'ambition', 'target', 'goal', 'plan', 'potential', 'work towards', 'may', 'milestone', 'objectives', 'outlook', 'probably', 'project', 'risk', 'seek', 'continue', 'projected', 'estimate', 'achieve' or the negative of these terms, and other similar expressions of future performance, results, actions or events, and their negatives, are intended to identify such forward-looking statements. Forward-looking statements also include, but are not limited to, statements and information regarding Unilever's acceleration of its Growth Action Plan, Unilever's portfolio optimisation towards global or scalable brands, the capabilities and potential of such brands, the various aspects of the separation of Ice Cream and its future operational model, strategy, growth potential, performance and returns, Unilever's productivity programme, its impacts and cost savings over the next three years and operation dis-synergies from the separation of Ice Cream, the Group's emissions reduction targets and other climate change related matters (including actions, potential impacts and risks associated therewith). Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Group (including during management presentations) in connection with this announcement. These forward-looking statements are based upon current beliefs, expectations and assumptions regarding anticipated developments and other factors affecting the Group. They are not historical facts, nor are they guarantees of future performance or outcomes. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements.

Because these forward-looking statements involve known and unknown risks and uncertainties, a number of which may be beyond the Group's control, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially from the forward-looking statements expressed in this announcement are: Unilever's ability to successfully separate Ice Cream and realise the anticipated benefits of the separation; Unilever's ability to successfully execute and consummate its productivity programme in line with expected costs to achieve expected savings; Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in Unilever's supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters.

The forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any intention, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. New risks and uncertainties arise over time, and it is not possible for us to predict those events or how they may affect us. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2023 and the Unilever Annual Report and Accounts 2023.

Enquiries

Media: Media Relations Team			Investors: Investor Relations Team
UK	+44 78 2527 3767	lucila.zambrano@unilever.com	investor.relations@unilever.com
or	+44 77 7999 9683	jonathan.sibun@teneo.com
NL	+31 62 191 3705	kiran.hofker@unilever.com
or	+31 61 500 8293	fleur-van.bruggen@unilever.com

After the conference call on 24 October 2024 at 8:00 AM (UK time), the webcast of the presentation will be available at: www.unilever.com/investor-relations/results-and-presentations/latest-results.

This Results Presentation has been submitted to the FCA National Storage Mechanism and is available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.